These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 12416599)

  • 1. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
    Sun SX; Liu GG; Christensen DB; Fu AZ
    Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of barriers to medication adherence in schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
    J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics.
    Lang K; Meyers JL; Korn JR; Lee S; Sikirica M; Crivera C; Dirani R; Menzin J
    Psychiatr Serv; 2010 Dec; 61(12):1239-47. PubMed ID: 21123409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
    Olfson M; Mechanic D; Hansell S; Boyer CA; Walkup J; Weiden PJ
    Psychiatr Serv; 2000 Feb; 51(2):216-22. PubMed ID: 10655006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.
    Velligan DI; Sajatovic M; Hatch A; Kramata P; Docherty JP
    Patient Prefer Adherence; 2017; 11():449-468. PubMed ID: 28424542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
    Svestka J; Bitter I
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.
    Elbogen EB; Swanson JW; Swartz MS; Van Dorn R
    J Nerv Ment Dis; 2005 Oct; 193(10):673-9. PubMed ID: 16208163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
    Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
    Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.
    Uhlmann C; Kaehler J; Harris MS; Unser J; Arolt V; Lencer R
    J Psychiatr Pract; 2014 Sep; 20(5):405-10. PubMed ID: 25226204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving adherence to antipsychotic pharmacotherapy.
    Masand PS; Narasimhan M
    Curr Clin Pharmacol; 2006 Jan; 1(1):47-56. PubMed ID: 18666377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence in patients with schizophrenia.
    Phan SV
    Int J Psychiatry Med; 2016; 51(2):211-9. PubMed ID: 27079779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.